Ledger.Open graph →

SEC Form D · filed November 27, 2013

Cingulate Therapeutics

Offering

—

Sold

$75K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MORRISTOWN, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Thomas J. Marusak · Albany, NYDirector David C. Michaels · Albany, NYDirector Frederick W. Jones · Albany, NYDirector Jeff Kellam · Longview, TXDirector Swapnil Agarwal · HOUSTON, TXExec William P. Phelan · Albany, NYExec McB Kh, LLC · Longview, TXExec George A. Overholser · KIRKLAND, WAExec · Director William A. Ruckelshaus · KIRKLAND, WAExec Timothy Harrington · Rowayton, CTExec John H. Cox · Schaumburg, ILExec Arrun Kapoor · Durham, NCDirector David Griest · Durham, NCDirector Alan Kelley · Durham, NCDirector David Kirkpatrick · Durham, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗